Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|April 28, 2005
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in SpainEmilio Pérez-Trallero, Celia García-de-la-Fuente, César García-Rey, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007)Emilio Pérez-Trallero, Jose E Martín-Herrero, Ana Mazón, et al.
Science Translational Medicine|February 21, 2014
Making prospective registration of observational research a realityRafael Dal-Ré, John P Ioannidis, Michael B Bracken, et al.
Public Health Reviews|February 17, 2018
An ethics training specific for European public healthVictoria Camps, Ildefonso Hernández-Aguado, Angel Puyol, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
The ALFA project: A research platform to identify early pathophysiological features of Alzheimer's diseaseJosé Luis Molinuevo, Nina Gramunt, Juan Domingo Gispert, et al.
Scientific Reports|September 6, 2017
Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effectsClara I Gomez-Sanchez, Juan J Carballo, Rosa Riveiro-Alvarez, et al.
Behavioral and Brain Functions : BBF|January 10, 2016
Attention deficit hyperactivity disorder: genetic association study in a cohort of Spanish childrenClara I Gomez-Sanchez, Rosa Riveiro-Alvarez, Victor Soto-Insuga, et al.
Pharmacogenomics|December 3, 2010
Evaluating a newly developed pharmacogenetic array: screening in a Spanish populationBerta Almoguera, Rosa Riveiro-Alvarez, Belen Gomez-Dominguez, et al.
Pharmacogenetics and Genomics|September 13, 2013
CYP2D6 poor metabolizer status might be associated with better response to risperidone treatmentBerta Almoguera, Rosa Riveiro-Alvarez, Jorge Lopez-Castroman, et al.
The Lancet. Infectious Diseases|May 21, 2021
Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunitiesRafael Dal-Ré, Linda-Gail Bekker, Christian Gluud, et al.
Pageof 9